JRJürgen RockstrohMDSlidesetHIVRussian HIV Clinical Forum 2018Two Drug Regimens - Pros and Cons | Jürgen Rockstroh, MDView Slideset
SlidesetHIVRussian HIV Clinical Forum 2018Clinical Case presentation | Elena Orlova-Morozova, PhDView Slideset
APAnton PozniakMD, FRCPSlidesetHIVGlobal HIV Clinical Forum 2018What is the Clinical support for reduce drug regimens? | Anton Pozniak, MD, FRCPView Slideset
SlidesetHIVGlobal HIV Clinical Forum 2018One pill a day?: Integration novel delivery systems into routine care | Terry Blaschke, MDView Slideset
MSMauro SchechterMD, PhDSlidesetHIVGlobal HIV Clinical Forum 2018State of the ART: Integrase Inhibitors (clinical overview) | Mauro Schechter, MD, PhDView Slideset
GvdBGuido van den BerkMD, PhDSlidesetHIVGlobal HIV Clinical Forum 2018Designing e-health interventions for HIV care | Guido van den Berk, MD, PhDView Slideset
SlidesetHIVGlobal HIV Clinical Forum 2018Clinical case: Integrase Inhibitors in Africa | Julia Turner, MDView Slideset
RZRebecca ZashMDSlidesetHIVGlobal HIV Clinical Forum 2018Implication of the resent Dolutegravir data | Rebecca Zash, MDView Slideset
MPMiłosz ParczewskiMD, PhDSlidesetHIVGlobal HIV Clinical Forum 2018Expanding Integrase Inhibitors in the rest of Europe | Miłosz Parczewski, MD, PhDView Slideset
DBDavid BackPhDSlidesetHIVGlobal HIV Clinical Forum 2018What is the Pharmacological support for reduce drug regimens? | David Back, PhDView Slideset
DKDaniel KuritzkesMDSlidesetHIVGlobal HIV Clinical Forum 2018What is the Virological support for reduced drug regimens? | Daniel Kuritzkes, MDView Slideset
OSOmar SuedMSc, MD, PhDSlidesetHIVBrazilian HIV Clinical Forum 2018Reduced drug regimens - their place in routine practice- Omar Sued, MSc, MD, PhDView Slideset
